SEM · As filed with the SEC

Select Medical Holdings income statement, by quarter

The statement as Select Medical Holdings presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Condensed Consolidated Statements of Operations (unaudited) · USD thousands, except per-share amounts

USD thousands, except per-share amountsQ1 2026
3 months ended Mar 31, 2026
Q4 2025†
3 months ended Dec 31, 2025
Q3 2025
3 months ended Sep 30, 2025
Q2 2025
3 months ended Jun 30, 2025
Q1 2025
3 months ended Mar 31, 2025
Q4 2024†
3 months ended Dec 31, 2024
Revenue1,421,4761,396,634†1,363,4451,339,5791,353,1721,312,564†
Costs and expenses:
Cost of services, exclusive of depreciation and amortization1,246,0081,250,800†1,215,9951,184,1291,172,6111,175,099†
General and administrative39,38445,693†40,05035,66333,00880,197†
Depreciation and amortization—36,205†34,44234,84834,80836,283†
Depreciation and amortization37,666—————
Total costs and expenses1,323,0581,332,698†1,290,4871,254,6401,240,4271,291,579†
Other operating income—0†01,5920106†
Income from operations98,41863,936†72,95886,531112,74521,091†
Other income and expense:
Loss on early retirement of debt—0†0——(17,906)†
Equity in earnings of unconsolidated subsidiaries—15,399†12,99213,61812,51210,423†
Equity in earnings of unconsolidated subsidiaries12,011—————
Interest expense(28,336)(28,871)†(30,021)(29,978)(29,072)(28,551)†
Income before income taxes82,09350,464†55,92970,17196,185(14,943)†
Income tax expense18,31812,722†11,74912,29221,453(4,487)†
Income from continuing operations, net of tax—37,742†44,18057,87974,732(10,456)†
Income from discontinued business—0†00024,669†
Income tax expense from discontinued business—0†00010,457†
Income from discontinued operations, net of tax—0†00014,212†
Net income63,77537,742†44,18057,87974,7323,756†
Less: Net income attributable to non-controlling interests19,78017,568†15,38717,30818,05119,806†
Net income attributable to Select Medical Holdings Corporation43,99520,174†28,79340,57156,681(16,050)†
Income from continuing operations, net of tax—20,174†28,79340,57156,681(23,664)†
Income from discontinued operations, net of tax—0†0007,614†
Earnings per common share (Note 11):
Continuing operations - basic (in dollars per share)——0.230.320.44—
Continuing operations - diluted (in dollars per share)——0.230.320.44—
Discontinued operations - basic (in dollars per share)——0.000.000.00—
Discontinued operations - diluted (in dollars per share)——0.000.000.00—
Basic (in dollars per share)0.35—0.230.320.44—
Diluted (in dollars per share)0.35—0.230.320.44—

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.